openPR Logo
Press release

Gastroparesis Drugs Market 2022 | North America accounted for a major share of 61.3%

07-01-2022 06:54 PM CET | Health & Medicine

Press release from: Allied Market Research

According to a new report published by Allied Market Research, titled, Gastroparesis Drugs Market, by Drug Class, Disease Type, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global gastroparesis market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/4153
Key findings of the Gastroparesis Drugs Market:

Prokinetic agents segment accounted for more than four-fifths share of the global gastroparesis drugs market in 2016.
Botulinum toxin injection segment is expected to grow at a CAGR of 5.6% from 2017 to 2023.
Idiopathic gastroparesis segment accounted for around 34.9% share of the global gastroparesis drugs market in 2016.
Hospitals accounted for nearly two-fifths share of the global gastroparesis drugs market in 2016.
Pharmacies segment is expected to grow at a CAGR of 5.0% from 2017 to 2023

North America was the leading revenue contributor to the global gastroparesis drugs market, accounting for nearly one-third of the global market. This is attributed to the early approval of gastroparesis drugs and high use of these drugs due to rise in incidence of gastroparesis. However, Asia-Pacific is expected to grow at the highest CAGR of 5.5% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward gastroparesis drugs.

Gastroparesis affects the normal spontaneous movement of the muscles of stomach and interferes with the normal digestion, thus causing nausea, vomiting, and problems related with blood sugar levels & nutrition. Gastroparesis is caused due to diabetes or can develop after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, antiemetics, and others are developed to treat gastroparesis.

Key Market Segments

By Drug Class
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
By Disease Type
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
BY DISTRIBUTION CHANNEL
Hospitals
Pharmacies
Clinics
E-commerce

Key Market Players

ABBOTT LABORATORIES (ABBOTT ARZNEIMITTEL GMBH)
ALLERGAN PLC
ASTRAZENECA PLC
CADILA PHARMACEUTICALS LIMITED
ETX PHARMA, INC.
EVOKE PHARMA, INC.
GLAXOSMITHKLINE PLC
NEUROGASTRX, INC.
THERAVANCE BIOPHARMA, INC.
VALEANT PHARMACEUTICAL INTERNATIONAL, INC.

The major factors that drive the growth of the global gastroparesis drugs market are rise in number of surgeries that may lead to postoperative gastroparesis, increase in diabetic population, introduction of novel drugs, and surge in geriatric population. However, side effects associated with gastroparesis drugs and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and development of novel gastroparesis drugs are expected to provide lucrative opportunities to the market players.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4153

Contact:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastroparesis Drugs Market 2022 | North America accounted for a major share of 61.3% here

News-ID: 2669637 • Views: 295

More Releases from Allied Market Research

UV curable Resin Market Statistics 2026: Major Factors that can Increase the Glo …
Allied Market Research published a report, titled, "UV Curable Resin Market by Resin Type (Acrylated Epoxies, Acrylated Polyesters, Acrylated Urethanes, Acrylated Silicones, and Others) and Application (Coating, Packaging, Printing, Adhesives & Sealants, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026." According to the report, the global UV curable resin industry garnered $4.74 billion in 2018 and is expected to reach $9.76 billion by 2026, registering a CAGR of 9.4%
Wood Plastic Composites Market Value To Cross $12.6 Billion By 2030 | Growth Wit …
Allied Market Research published a report, titled, "Wood Plastic Composites Market by Application (Building and Construction, Automotive Components, Industrial and Consumer Products, Others), by Type (Polyethylene, Polyvinylchloride, Polypropylene, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030". According to the report, the global wood plastic composites industry generated $5.4 billion in 2020, and is anticipated to generate $12.6 billion by 2030, witnessing a CAGR of 8.9% from 2021 to 2030. Access Full
Insulation Materials Market to Generate $101.9 Billion By 2030 | Major Companies …
"Insulation Materials Market by Type (Mineral Wool, Polyurethane Foam, Polyethylene, Polyvinyl Chloride, Expanded Polystyrene, Extruded Polystyrene, and Others) and Application (Residential Construction, HVAC & OEM, Non-Residential, Wires & Cables, Automotive, Oil & Gas, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030". According to the report, the global insulation materials industry generated $61.6 billion in 2020, and is anticipated to generate $101.9 billion by 2030, witnessing a CAGR of 5.2%
Cross Border Ecommerce Market: A Latest Research Report to Share Market Insights …
Increase in trade liberalization, adoption of globalization, reduced cross line transaction formalities, penetration of mobile internet, development of retail industry and development level of consumer goods and services sector are some of the major factors for the growth of this market. However, shipping, logistics, customer demographic difference and changing international customer expectations are some of the factors which may hinder the growth of the market. Furthermore, technological advancement, government policies

All 5 Releases


More Releases for Gastroparesis

Develop business strategies Of Diabetic Gastroparesis - Pipeline Review, H1 2018
"The Report Diabetic Gastroparesis - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Diabetic Gastroparesis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2018, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581026 Gastroparesis is a long-term complication of diabetes
Diabetic Gastroparesis-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Diabetic Gastroparesis-Pipeline Review H1 2017” this report provides an overview of the Diabetic Gastroparesis-Pipeline landscape.  Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H1 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels can damage nerves in many parts
Gastroparesis Drugs Market, Growing $6,486 Million By 2023
The global gastroparesis market was valued at $4,667 million in 2016, and is projected to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023. Gastroparesis is a medical condition of the stomach, which affects the normal spontaneous movement of the muscles of the stomach. It restricts the normal digestion, causes vomiting, and problems related with blood sugar levels & nutrition. Various medications or drugs are prescribed to
Diabetic Gastroparesis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Diabetic Gastroparesis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Gastroparesis - Pipeline Review, H2 2017, provides an overview of the Diabetic Gastroparesis (Gastrointestinal) pipeline landscape. Gastroparesis is a long-term complication of diabetes that involves the stomach and affects digestion. Prolonged high blood sugar levels
Gastroparesis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, Gastroparesis Global Clinical Trials Review, H2, 2017" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status
Diabetic Gastroparesis - Pipeline Market Research Report, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Diabetic Gastroparesis - Pipeline Insight, 2017”. This report provides comprehensive insights about pipeline drugs across this Diabetic Gastroparesis. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Diabetic Gastroparesis. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1214082 This report provides information on the therapeutic development for